Hind Rafei Chairs Session on Novel Myeloid and T Cell Strategies at ASGCT 2026
Hind Rafei/X

Hind Rafei Chairs Session on Novel Myeloid and T Cell Strategies at ASGCT 2026

Hind Rafei, Assistant Professor at MD Anderson Cancer Center, shared a post on LinkedIn:

“I am very excited to be attending ASGCT 2026 where I will be chairing a session on novel myeloid and T cell strategies for cellular therapies on Tuesday.

Please reach out or come say hi if you are around and would like to meet and chat.”

Other articles about ASGCT on OncoDaily.